menu search

ALXO / ALX Oncology Holdings Inc. (ALXO) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

ALX Oncology Holdings Inc. (ALXO) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
ALX Oncology Holdings Inc. (ALXO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. Read More
Posted: Aug 10 2023, 11:31
Author Name: Zacks Investment Research
Views: 111377

ALXO News  

ALX Oncology: On Right Track With Latest Interim Analysis Of Evorpacept

By Seeking Alpha
October 9, 2023

ALX Oncology: On Right Track With Latest Interim Analysis Of Evorpacept

ALX Oncology reported positive interim results from its phase 2 study using its anti-CD47 drug for HER2-positive gastric/gastroesophageal junction can more_horizontal

ALX Oncology stock doubles on early data from phase II cancer trial

By Proactive Investors
October 3, 2023

ALX Oncology stock doubles on early data from phase II cancer trial

ALX Oncology Holdings Inc saw its stock value double in pre-market trading on the heels of promising interim data from a phase II study assessing th more_horizontal

ALX Oncology Holdings Inc. (ALXO) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

By Zacks Investment Research
August 10, 2023

ALX Oncology Holdings Inc. (ALXO) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

ALX Oncology Holdings Inc. (ALXO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled more_horizontal

ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference

By GlobeNewsWire
January 3, 2023

ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immun more_horizontal


Search within

Pages Search Results: